These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 22577915)
1. Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients. Jones C; Bennett K; Kim TW; Bulger TF; Pollock N Anaesth Intensive Care; 2012 May; 40(3):490-7. PubMed ID: 22577915 [TBL] [Abstract][Full Text] [Related]
2. Washout times of desflurane, sevoflurane and isoflurane from the GE Healthcare Aisys® and Avance®, Carestation®, and Aestiva® anesthesia system. Kim TW; Wingate JR; Fernandez AM; Whitaker E; Tham RQ Paediatr Anaesth; 2013 Dec; 23(12):1124-30. PubMed ID: 23947944 [TBL] [Abstract][Full Text] [Related]
3. Effects of fresh gas flow, tidal volume, and charcoal filters on the washout of sevoflurane from the Datex Ohmeda (GE) Aisys, Aestiva/5, and Excel 210 SE Anesthesia Workstations. Sabouri AS; Lerman J; Heard C Can J Anaesth; 2014 Oct; 61(10):935-42. PubMed ID: 25069780 [TBL] [Abstract][Full Text] [Related]
4. Preparing a new generation anaesthetic machine for patients susceptible to malignant hyperthermia. Schönell LH; Sims C; Bulsara M Anaesth Intensive Care; 2003 Feb; 31(1):58-62. PubMed ID: 12635397 [TBL] [Abstract][Full Text] [Related]
5. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia. Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705 [TBL] [Abstract][Full Text] [Related]
6. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients. Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266 [TBL] [Abstract][Full Text] [Related]
7. Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study. Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S Eur J Anaesthesiol; 2019 Nov; 36(11):851-856. PubMed ID: 31580288 [TBL] [Abstract][Full Text] [Related]
8. Washout of sevoflurane from the GE Avance and Amingo Carestation anesthetic machines. Brünner HW; Pohl S; Grond S Acta Anaesthesiol Scand; 2011 Oct; 55(9):1118-23. PubMed ID: 22092210 [TBL] [Abstract][Full Text] [Related]
9. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient. Gunter JB; Ball J; Than-Win S Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of inhaled agent usage displays of automated target control anesthesia machines. Dehouwer A; Carette R; De Ridder S; De Wolf AM; Hendrickx JF J Clin Monit Comput; 2016 Oct; 30(5):539-43. PubMed ID: 26249754 [TBL] [Abstract][Full Text] [Related]
12. Desflurane consumption with automated vapour control systems in two different anaesthesia machines. A randomized controlled study. Mostad D; Klepstad P; Follestad T; Pleym H Acta Anaesthesiol Scand; 2021 Aug; 65(7):895-901. PubMed ID: 33788249 [TBL] [Abstract][Full Text] [Related]
13. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients. Heiderich S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Reitz M; Rüffert H BMC Anesthesiol; 2021 Dec; 21(1):315. PubMed ID: 34903173 [TBL] [Abstract][Full Text] [Related]
15. Economic and Environmental Considerations During Low Fresh Gas Flow Volatile Agent Administration After Change to a Nonreactive Carbon Dioxide Absorbent. Epstein RH; Dexter F; Maguire DP; Agarwalla NK; Gratch DM Anesth Analg; 2016 Apr; 122(4):996-1006. PubMed ID: 26735317 [TBL] [Abstract][Full Text] [Related]
16. Comparison of an infrared anaesthetic agent analyser (Datex-Ohmeda) with refractometry for measurement of isoflurane, sevoflurane and desflurane concentrations. Rudolff AS; Moens YP; Driessen B; Ambrisko TD Vet Anaesth Analg; 2014 Jul; 41(4):386-92. PubMed ID: 24330264 [TBL] [Abstract][Full Text] [Related]
17. Automated control of end-tidal inhalation anaesthetic concentration using the GE Aisys Carestation™. Singaravelu S; Barclay P Br J Anaesth; 2013 Apr; 110(4):561-6. PubMed ID: 23293274 [TBL] [Abstract][Full Text] [Related]
18. Arterial to inspired partial pressure ratio of halothane, isoflurane, sevoflurane and desflurane in rats. Holdcroft A; Bose D; Sapsed-Byrne SM; Ma D; Lockwood GG Br J Anaesth; 1999 Oct; 83(4):618-21. PubMed ID: 10673881 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs. Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377 [TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomics of volatile inhalational anaesthetic agents: an 11-year retrospective analysis. Weinberg L; Story D; Nam J; McNicol L Anaesth Intensive Care; 2010 Sep; 38(5):849-54. PubMed ID: 20865868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]